PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

102 hedge funds and large institutions have $92.4M invested in Invesco Biotechnology & Genome ETF in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 35 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+3
Holders Change %
+3.03%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
14
Reduced
35
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$1.21M
2
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
$1.55M
3
GM
GeoWealth Management
Illinois
$877K
4
Two Sigma Investments
Two Sigma Investments
New York
$433K
5
Goldman Sachs
Goldman Sachs
New York
$408K

Top Sellers

1
GKWIM
Gerber Kawasaki Wealth & Investment Management
California
$15.2M
2
Morgan Stanley
Morgan Stanley
New York
$13.6M
3
LPL Financial
LPL Financial
California
$6.33M
4
CW
CreativeOne Wealth
Kansas
$1.92M
5
Bank of America
Bank of America
North Carolina
$4.67M
Name Holding Trade Value Shares
Change 		Shares
Change %
CAS
101
Coppell Advisory Solutions
Texas
$2.58K +$2.58K +37 New
BBPWM
102
Blue Bell Private Wealth Management
Pennsylvania
$1.47K – – –
HNB
103
Huntington National Bank
Ohio
$70 -$65 – –
EH
104
Equitable Holdings
New York
– -$227K -3,510 Closed
CA
105
Continuum Advisory
Idaho
– -$31.8K -490 Closed
UB
106
UMB Bank
Missouri
– -$31.1K -480 Closed
ATPW
107
Ashton Thomas Private Wealth
Arizona
– -$25.9K -400 Closed
CCM
108
Chilton Capital Management
Texas
– -$12.3K -190 Closed
AF
109
Allworth Financial
California
– -$11.4K -167 Closed
TSWM
110
Tyler-Stone Wealth Management
Ohio
– -$4.67K -72 Closed
1 2 3 4
5